Trials / Sponsors / Ou Bai, MD/PHD
Ou Bai, MD/PHD
Academic / Other · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 3 | 2026-05-30 |
| Recruiting | Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/B Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | 2026-04-30 |
| Not Yet Recruiting | A Real-World Study of Pirtobrutinib in cBTKi-Resistant/Intolerant Mature B-Cell Lymphoma Mature B-Cell Lymphoma | — | 2026-04-01 |
| Unknown | the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma Lymphoma | N/A | 2023-05-01 |
| Unknown | Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lympho Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma | N/A | 2023-03-23 |
| Completed | Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma Diffuse Large B-cell Lymphoma | Phase 2 | 2017-06-01 |